Behind the headlines here at ASCO, you’ll find one of the biggest players in immuno-oncology quietly positioning itself to grab a leading role in the fast-emerging market.

…read more

Source: Genentech’s PD-L1 breakthrough star ‘atezo’ positioned to vault ahead on cancer